These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38861603)

  • 21. Zika Virus Attenuation by Codon Pair Deoptimization Induces Sterilizing Immunity in Mouse Models.
    Li P; Ke X; Wang T; Tan Z; Luo D; Miao Y; Sun J; Zhang Y; Liu Y; Hu Q; Xu F; Wang H; Zheng Z
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic stability of RSV-F expression and the restricted growth phenotype of a live attenuated PIV3 vectored RSV vaccine candidate (MEDI-534) following restrictive growth in human lung cells.
    Nelson CL; Tang RS; Stillman EA
    Vaccine; 2013 Aug; 31(36):3756-62. PubMed ID: 23623857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A live attenuated recombinant chimeric parainfluenza virus (PIV) candidate vaccine containing the hemagglutinin-neuraminidase and fusion glycoproteins of PIV1 and the remaining proteins from PIV3 induces resistance to PIV1 even in animals immune to PIV3.
    Tao T; Davoodi F; Cho CJ; Skiadopoulos MH; Durbin AP; Collins PL; Murphy BR
    Vaccine; 2000 Jan; 18(14):1359-66. PubMed ID: 10618533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attenuation of human respiratory syncytial virus by genome-scale codon-pair deoptimization.
    Le Nouën C; Brock LG; Luongo C; McCarty T; Yang L; Mehedi M; Wimmer E; Mueller S; Collins PL; Buchholz UJ; DiNapoli JM
    Proc Natl Acad Sci U S A; 2014 Sep; 111(36):13169-74. PubMed ID: 25157129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of two chimeric bovine-human parainfluenza virus type 3 vaccines in infants and young children.
    Karron RA; Thumar B; Schappell E; Surman S; Murphy BR; Collins PL; Schmidt AC
    Vaccine; 2012 Jun; 30(26):3975-81. PubMed ID: 22178099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attenuation and efficacy of human parainfluenza virus type 1 (HPIV1) vaccine candidates containing stabilized mutations in the P/C and L genes.
    Bartlett EJ; Castaño A; Surman SR; Collins PL; Skiadopoulos MH; Murphy BR
    Virol J; 2007 Jul; 4():67. PubMed ID: 17605811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimization of the Codon Pair Usage of Human Respiratory Syncytial Virus Paradoxically Resulted in Reduced Viral Replication
    Le Nouën C; Luongo CL; Yang L; Mueller S; Wimmer E; DiNapoli JM; Collins PL; Buchholz UJ
    J Virol; 2020 Jan; 94(2):. PubMed ID: 31666376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The immunogenicity and efficacy of intranasally or parenterally administered replication-deficient vaccinia-parainfluenza virus type 3 recombinants in rhesus monkeys.
    Durbin AP; Wyatt LS; Siew J; Moss B; Murphy BR
    Vaccine; 1998 Aug; 16(13):1324-30. PubMed ID: 9682397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A chimeric human-bovine parainfluenza virus type 3 expressing measles virus hemagglutinin is attenuated for replication but is still immunogenic in rhesus monkeys.
    Skiadopoulos MH; Surman SR; Riggs JM; Collins PL; Murphy BR
    J Virol; 2001 Nov; 75(21):10498-504. PubMed ID: 11581420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rescue of codon-pair deoptimized respiratory syncytial virus by the emergence of genomes with very large internal deletions that complemented replication.
    Le Nouën C; McCarty T; Yang L; Brown M; Wimmer E; Collins PL; Buchholz UJ
    Proc Natl Acad Sci U S A; 2021 Mar; 118(13):. PubMed ID: 33753491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations in the C, D, and V open reading frames of human parainfluenza virus type 3 attenuate replication in rodents and primates.
    Durbin AP; McAuliffe JM; Collins PL; Murphy BR
    Virology; 1999 Sep; 261(2):319-30. PubMed ID: 10497117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sendai virus recombinant vaccine expressing hPIV-3 HN or F elicits protective immunity and combines with a second recombinant to prevent hPIV-1, hPIV-3 and RSV infections.
    Zhan X; Slobod KS; Krishnamurthy S; Luque LE; Takimoto T; Jones B; Surman S; Russell CJ; Portner A; Hurwitz JL
    Vaccine; 2008 Jun; 26(27-28):3480-8. PubMed ID: 18499307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic stability of genome-scale deoptimized RNA virus vaccine candidates under selective pressure.
    Le Nouën C; McCarty T; Brown M; Smith ML; Lleras R; Dolan MA; Mehedi M; Yang L; Luongo C; Liang B; Munir S; DiNapoli JM; Mueller S; Wimmer E; Collins PL; Buchholz UJ
    Proc Natl Acad Sci U S A; 2017 Jan; 114(3):E386-E395. PubMed ID: 28049853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A live attenuated chimeric recombinant parainfluenza virus (PIV) encoding the internal proteins of PIV type 3 and the surface glycoproteins of PIV type 1 induces complete resistance to PIV1 challenge and partial resistance to PIV3 challenge.
    Tao T; Skiadopoulos MH; Durbin AP; Davoodi F; Collins PL; Murphy BR
    Vaccine; 1999 Mar; 17(9-10):1100-8. PubMed ID: 10195620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of a parainfluenza virus type 1 vaccine candidate by replacing the HN and F glycoproteins of the live-attenuated PIV3 cp45 vaccine virus with their PIV1 counterparts.
    Skiadopoulos MH; Tao T; Surman SR; Collins PL; Murphy BR
    Vaccine; 1999 Oct; 18(5-6):503-10. PubMed ID: 10519940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a PIV-vectored RSV vaccine: preclinical evaluation of safety, toxicity, and enhanced disease and initial clinical testing in healthy adults.
    Tang RS; Spaete RR; Thompson MW; MacPhail M; Guzzetta JM; Ryan PC; Reisinger K; Chandler P; Hilty M; Walker RE; Gomez MM; Losonsky GA
    Vaccine; 2008 Nov; 26(50):6373-82. PubMed ID: 18822334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attenuated Human Parainfluenza Virus Type 1 Expressing Ebola Virus Glycoprotein GP Administered Intranasally Is Immunogenic in African Green Monkeys.
    Lingemann M; Liu X; Surman S; Liang B; Herbert R; Hackenberg AD; Buchholz UJ; Collins PL; Munir S
    J Virol; 2017 May; 91(10):. PubMed ID: 28250127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primates.
    Bukreyev A; Huang Z; Yang L; Elankumaran S; St Claire M; Murphy BR; Samal SK; Collins PL
    J Virol; 2005 Nov; 79(21):13275-84. PubMed ID: 16227250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinants of the host range restriction of replication of bovine parainfluenza virus type 3 in rhesus monkeys are polygenic.
    Skiadopoulos MH; Schmidt AC; Riggs JM; Surman SR; Elkins WR; St Claire M; Collins PL; Murphy BR
    J Virol; 2003 Jan; 77(2):1141-8. PubMed ID: 12502830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model.
    Wyatt LS; Shors ST; Murphy BR; Moss B
    Vaccine; 1996 Oct; 14(15):1451-8. PubMed ID: 8994321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.